Marshall Wace, LLP Biocept Inc Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.88 - $2.27 $81,672 - $210,678
-92,810 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.83 - $3.97 $116,060 - $251,781
-63,421 Reduced 40.59%
92,810 $215,000
Q4 2021

Feb 14, 2022
BUY
$3.43 - $4.22 $175,790 - $216,279
51,251 Added 48.82%
156,231 $566,000
Q3 2021

Nov 15, 2021
BUY
$3.39 - $4.34 $355,882 - $455,613
104,980 New
104,980 $421,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email